<p>Brookstone Capital Management 在最近向 SEC 提交的 13F 文件中表示，在第三季度將其在 Intuitive Surgical, Inc.（NASDAQ:ISRG - 免費報告）的持股增加了 48.7%。該公司在本季度購買了 12,014 股後，持有該醫療設備提供商的 36,707 股股票。Brookstone Capital Management 在 Intuitive Surgical 的持股在最近一個季度末的價值為 16,416,000 美元。</p>
<p>獲取 <strong>Intuitive Surgical</strong> 提醒：</p>
<ul>
<li>1.34 億美元的內部交易：這對 KMI、ISRG 和 QS 可能意味着什麼</li>
</ul>
<p>其他對沖基金也買賣了該公司的股票。挪威銀行在第二季度購買了價值約 25.69 億美元的 Intuitive Surgical 新股份。先鋒集團在第二季度將其在 Intuitive Surgical 的持股增加了 2.1%。先鋒集團目前擁有 33,335,833 股該醫療設備提供商的股票，價值為 181.15 億美元，此前在該期間內又購買了 670,302 股。瑞銀資產管理的一個獨立業務單位在第一季度將其在 Intuitive Surgical 的持股增加了 20.1%。瑞銀資產管理的該獨立業務單位目前擁有 3,393,951 股該醫療設備提供商的股票，價值為 16.81 億美元，此前在該期間內又購買了 566,979 股。Jennison Associates LLC 在第二季度將其在 Intuitive Surgical 的持股增加了 20.4%。Jennison Associates LLC 目前擁有 3,122,390 股該醫療設備提供商的股票，價值為 16.97 億美元，此前在上個季度又購買了 528,359 股。最後，貝斯默集團在第二季度將其在 Intuitive Surgical 的持股增加了 89.3%。貝斯默集團目前擁有 788,328 股該醫療設備提供商的股票，價值為 4.28386 億美元，此前在該期間內又購買了 371,806 股。機構投資者持有該公司 83.64% 的股票。</p>
<h2>Intuitive Surgical 股票上漲 0.1%</h2>
<p>Intuitive Surgical 的股票在週四以 578.10 美元開盤。該公司的市值為 2072.4 億美元，市盈率為 76.47，PEG 比率為 5.28，貝塔值為 1.68。該公司的 50 日移動平均價格為 550.03 美元，200 日移動平均價格為 506.41 美元。Intuitive Surgical, Inc.的 12 個月低點為 425.00 美元，12 個月高點為 616.00 美元。</p>
<ul>
<li>在特朗普關税政策下表現突出的前三隻股票</li>
</ul>
<p>Intuitive Surgical（NASDAQ:ISRG - 獲取免費報告）最近於 10 月 21 日（星期二）公佈了季度財報。該醫療設備提供商報告本季度每股收益為 2.40 美元，超出分析師一致預期的 1.99 美元，超出幅度為 0.41 美元。Intuitive Surgical 的股本回報率為 15.08%，淨利潤率為 28.58%。該公司在本季度的收入為 25.1 億美元，而分析師預期為 24.1 億美元。在去年同期，該公司每股收益為 1.84 美元。該公司的收入同比增長 22.9%。平均而言，股票分析師預計 Intuitive Surgical, Inc.在當前財政年度將發佈 6.43 美元的每股收益。</p>
<h2>內部活動</h2>
<p>在相關消息中，高級副總裁 Mark Brosius 於 12 月 12 日（星期五）出售了 4,500 股公司的股票。該股票以平均價格 547.36 美元出售，總價值為 2,463,120.00 美元。交易完成後，該高級副總裁直接持有 907 股公司的股票，價值約為 496,455.52 美元。此交易代表其持股減少了 83.23%。該交易已在向 SEC 提交的文件中披露，可以通過此超鏈接訪問。此外，首席執行官 David J. Rosa 於 10 月 24 日（星期五）出售了 24,500 股公司的股票。該股票以平均價格 547.55 美元出售，總交易額為 13,414,975.00 美元。出售後，首席執行官直接持有 234,256 股公司的股票，價值約為 128,266,872.80 美元。該交易使其持股減少了 9.47%。該銷售的 SEC 文件提供了更多信息。在過去的九十天裏，內部人士出售了 114,007 股公司股票，價值為 63,533,844 美元。0.70% 的股票由公司內部人士持有。</p>
<h2>分析師評級變動</h2>
<ul>
<li>為什麼 Intuitive Surgical 對長期投資者來説是個明智之選</li>
</ul>
<p>幾位分析師最近對 ISRG 股票發表了評論。Evercore ISI 在 10 月 22 日（星期三）的研究報告中將 Intuitive Surgical 的目標價格從 450.00 美元上調至 540.00 美元。富國銀行在 12 月 12 日（星期五）將 Intuitive Surgical 的目標價格從 600.00 美元上調至 654.00 美元，並給予該公司 “超配” 評級。Leerink Partners 在 10 月 22 日（星期三）的研究報告中將 Intuitive Surgical 的目標價格從 593.00 美元上調至 600.00 美元，並給予該公司 “跑贏大盤” 評級。大和資本市場在 10 月 24 日（星期五）將 Intuitive Surgical 的目標價格從 510.00 美元上調至 550.00 美元，並給予該股票 “跑贏大盤” 評級。最後，Argus 在 10 月 27 日（星期一）的研究報告中將 Intuitive Surgical 的目標價格從 600.00 美元上調至 630.00 美元。兩位股票研究分析師對該股票給予 “強烈買入” 評級，十六位給予 “買入” 評級，八位給予 “持有” 評級，一位給予 “賣出” 評級。根據 MarketBeat.com 的數據，該公司目前的平均評級為 “適度買入”，平均目標價格為 611.08 美元。</p>
<p><strong>獲取我們最新的 ISRG 研究報告</strong></p>
<h2>Intuitive Surgical 公司簡介</h2>
<p>（免費報告）</p>
<p>直覺外科成立於 1995 年，總部位於加利福尼亞州的陽光谷，是一家專注於設計、製造和服務機器人輔助手術系統的醫療科技公司。該公司以其達芬奇手術系統而聞名，該系統通過將外科醫生的手部動作轉化為患者體內小型儀器的更精細、縮放的運動，從而實現微創手術。直覺外科的業務主要集中在向醫院和手術中心提供系統、儀器及相關技術，旨在提高手術室內的精確度、可視化和控制能力。</p>
<p>除了核心手術平台外，直覺外科還銷售一系列可重複使用和一次性使用的儀器、配件和專有軟件，併為客户提供培訓、服務和臨牀支持。</p>
<h2>進一步閲讀</h2>
<ul>
<li>五隻我們更看好的股票，勝過直覺外科</li>
<li>請勿刪除，立即閲讀</li>
<li>投資者警報：微型 “$3 AI 奇蹟股票” 即將騰飛</li>
<li>任何費用可以從資本利得税中扣除嗎？</li>
<li>巴菲特、蓋茨和貝索斯悄悄拋售股票——原因在這裏</li>
<li>忘掉 AI 吧，這將是下一個重大科技突破</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資$1,000 在直覺外科嗎？</h2>
<p>在考慮直覺外科之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而直覺外科並不在名單上。</p>
<p>雖然直覺外科目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

直覺外科

<p>Brookstone Capital Management 在第三季度將其在直覺外科公司的股份增加了 48.7%，目前持有 36,707 股，價值 1,642 萬美元。其他對沖基金也增加了他們的持倉。直覺外科報告了強勁的第三季度財報，營收同比增長 22.9%。內部人士的活動包括高管的大量股票出售。分析師提高了對該股票的目標價</p>

<p>Brookstone Capital Management increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 48.7% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 36,707 shares of the medical equipment provider's stock after purchasing an additional 12,014 shares during the quarter. Brookstone Capital Management's holdings in Intuitive Surgical were worth $16,416,000 at the end of the most recent quarter.</p>
<div class="lb-trans"><p>Brookstone Capital Management 在最近向 SEC 提交的 13F 文件中表示，在第三季度將其在 Intuitive Surgical, Inc.（NASDAQ:ISRG - 免費報告）的持股增加了 48.7%。該公司在本季度購買了 12,014 股後，持有該醫療設備提供商的 36,707 股股票。Brookstone Capital Management 在 Intuitive Surgical 的持股在最近一個季度末的價值為 16,416,000 美元。</p>
</div><p>Get <strong>Intuitive Surgical</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Intuitive Surgical</strong> 提醒：</p>
</div><ul>
<li>$134M in Insider Moves: What It Might Mean for KMI, ISRG and QS</li>
</ul>
<div class="lb-trans"><ul>
<li>1.34 億美元的內部交易：這對 KMI、ISRG 和 QS 可能意味着什麼</li>
</ul>
</div><p>Other hedge funds have also bought and sold shares of the company. Norges Bank purchased a new position in shares of Intuitive Surgical during the 2nd quarter valued at about $2,569,260,000. Vanguard Group Inc. raised its stake in Intuitive Surgical by 2.1% during the 2nd quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider's stock worth $18,115,025,000 after acquiring an additional 670,302 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Intuitive Surgical by 20.1% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,393,951 shares of the medical equipment provider's stock worth $1,680,922,000 after acquiring an additional 566,979 shares during the period. Jennison Associates LLC lifted its holdings in Intuitive Surgical by 20.4% during the second quarter. Jennison Associates LLC now owns 3,122,390 shares of the medical equipment provider's stock valued at $1,696,738,000 after purchasing an additional 528,359 shares in the last quarter. Finally, Bessemer Group Inc. boosted its position in shares of Intuitive Surgical by 89.3% in the second quarter. Bessemer Group Inc. now owns 788,328 shares of the medical equipment provider's stock worth $428,386,000 after purchasing an additional 371,806 shares during the period. Institutional investors own 83.64% of the company's stock.</p>
<div class="lb-trans"><p>其他對沖基金也買賣了該公司的股票。挪威銀行在第二季度購買了價值約 25.69 億美元的 Intuitive Surgical 新股份。先鋒集團在第二季度將其在 Intuitive Surgical 的持股增加了 2.1%。先鋒集團目前擁有 33,335,833 股該醫療設備提供商的股票，價值為 181.15 億美元，此前在該期間內又購買了 670,302 股。瑞銀資產管理的一個獨立業務單位在第一季度將其在 Intuitive Surgical 的持股增加了 20.1%。瑞銀資產管理的該獨立業務單位目前擁有 3,393,951 股該醫療設備提供商的股票，價值為 16.81 億美元，此前在該期間內又購買了 566,979 股。Jennison Associates LLC 在第二季度將其在 Intuitive Surgical 的持股增加了 20.4%。Jennison Associates LLC 目前擁有 3,122,390 股該醫療設備提供商的股票，價值為 16.97 億美元，此前在上個季度又購買了 528,359 股。最後，貝斯默集團在第二季度將其在 Intuitive Surgical 的持股增加了 89.3%。貝斯默集團目前擁有 788,328 股該醫療設備提供商的股票，價值為 4.28386 億美元，此前在該期間內又購買了 371,806 股。機構投資者持有該公司 83.64% 的股票。</p>
</div><h2>Intuitive Surgical Stock Up 0.1%</h2>
<div class="lb-trans"><h2>Intuitive Surgical 股票上漲 0.1%</h2>
</div><p>Shares of Intuitive Surgical stock opened at $578.10 on Thursday. The firm has a market cap of $207.24 billion, a price-to-earnings ratio of 76.47, a PEG ratio of 5.28 and a beta of 1.68. The business has a 50-day moving average price of $550.03 and a 200-day moving average price of $506.41. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00.</p>
<div class="lb-trans"><p>Intuitive Surgical 的股票在週四以 578.10 美元開盤。該公司的市值為 2072.4 億美元，市盈率為 76.47，PEG 比率為 5.28，貝塔值為 1.68。該公司的 50 日移動平均價格為 550.03 美元，200 日移動平均價格為 506.41 美元。Intuitive Surgical, Inc.的 12 個月低點為 425.00 美元，12 個月高點為 616.00 美元。</p>
</div><ul>
<li>Top 3 Stocks Powering Through Trump’s Tariff Policies</li>
</ul>
<div class="lb-trans"><ul>
<li>在特朗普關税政策下表現突出的前三隻股票</li>
</ul>
</div><p>Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating analysts' consensus estimates of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. During the same period in the prior year, the company earned $1.84 earnings per share. The firm's revenue was up 22.9% on a year-over-year basis. On average, equities analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Intuitive Surgical（NASDAQ:ISRG - 獲取免費報告）最近於 10 月 21 日（星期二）公佈了季度財報。該醫療設備提供商報告本季度每股收益為 2.40 美元，超出分析師一致預期的 1.99 美元，超出幅度為 0.41 美元。Intuitive Surgical 的股本回報率為 15.08%，淨利潤率為 28.58%。該公司在本季度的收入為 25.1 億美元，而分析師預期為 24.1 億美元。在去年同期，該公司每股收益為 1.84 美元。該公司的收入同比增長 22.9%。平均而言，股票分析師預計 Intuitive Surgical, Inc.在當前財政年度將發佈 6.43 美元的每股收益。</p>
</div><h2>Insider Activity</h2>
<div class="lb-trans"><h2>內部活動</h2>
</div><p>In related news, SVP Mark Brosius sold 4,500 shares of the firm's stock in a transaction on Friday, December 12th. The shares were sold at an average price of $547.36, for a total value of $2,463,120.00. Following the completion of the transaction, the senior vice president directly owned 907 shares of the company's stock, valued at approximately $496,455.52. This trade represents a 83.23% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO David J. Rosa sold 24,500 shares of the company's stock in a transaction on Friday, October 24th. The shares were sold at an average price of $547.55, for a total transaction of $13,414,975.00. Following the sale, the chief executive officer directly owned 234,256 shares in the company, valued at approximately $128,266,872.80. The trade was a 9.47% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 114,007 shares of company stock worth $63,533,844. 0.70% of the stock is owned by corporate insiders.</p>
<div class="lb-trans"><p>在相關消息中，高級副總裁 Mark Brosius 於 12 月 12 日（星期五）出售了 4,500 股公司的股票。該股票以平均價格 547.36 美元出售，總價值為 2,463,120.00 美元。交易完成後，該高級副總裁直接持有 907 股公司的股票，價值約為 496,455.52 美元。此交易代表其持股減少了 83.23%。該交易已在向 SEC 提交的文件中披露，可以通過此超鏈接訪問。此外，首席執行官 David J. Rosa 於 10 月 24 日（星期五）出售了 24,500 股公司的股票。該股票以平均價格 547.55 美元出售，總交易額為 13,414,975.00 美元。出售後，首席執行官直接持有 234,256 股公司的股票，價值約為 128,266,872.80 美元。該交易使其持股減少了 9.47%。該銷售的 SEC 文件提供了更多信息。在過去的九十天裏，內部人士出售了 114,007 股公司股票，價值為 63,533,844 美元。0.70% 的股票由公司內部人士持有。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析師評級變動</h2>
</div><ul>
<li>Why Intuitive Surgical Is a No-Brainer for Long-Term Investors</li>
</ul>
<div class="lb-trans"><ul>
<li>為什麼 Intuitive Surgical 對長期投資者來説是個明智之選</li>
</ul>
</div><p>Several analysts have recently commented on ISRG shares. Evercore ISI raised their price objective on shares of Intuitive Surgical from $450.00 to $540.00 in a research report on Wednesday, October 22nd. Wells Fargo &amp; Company raised their price target on Intuitive Surgical from $600.00 to $654.00 and gave the company an &#34;overweight&#34; rating in a report on Friday, December 12th. Leerink Partners boosted their price objective on Intuitive Surgical from $593.00 to $600.00 and gave the company an &#34;outperform&#34; rating in a research report on Wednesday, October 22nd. Daiwa Capital Markets increased their target price on Intuitive Surgical from $510.00 to $550.00 and gave the stock an &#34;outperform&#34; rating in a research report on Friday, October 24th. Finally, Argus lifted their target price on Intuitive Surgical from $600.00 to $630.00 in a research note on Monday, October 27th. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of &#34;Moderate Buy&#34; and an average target price of $611.08.</p>
<div class="lb-trans"><p>幾位分析師最近對 ISRG 股票發表了評論。Evercore ISI 在 10 月 22 日（星期三）的研究報告中將 Intuitive Surgical 的目標價格從 450.00 美元上調至 540.00 美元。富國銀行在 12 月 12 日（星期五）將 Intuitive Surgical 的目標價格從 600.00 美元上調至 654.00 美元，並給予該公司 “超配” 評級。Leerink Partners 在 10 月 22 日（星期三）的研究報告中將 Intuitive Surgical 的目標價格從 593.00 美元上調至 600.00 美元，並給予該公司 “跑贏大盤” 評級。大和資本市場在 10 月 24 日（星期五）將 Intuitive Surgical 的目標價格從 510.00 美元上調至 550.00 美元，並給予該股票 “跑贏大盤” 評級。最後，Argus 在 10 月 27 日（星期一）的研究報告中將 Intuitive Surgical 的目標價格從 600.00 美元上調至 630.00 美元。兩位股票研究分析師對該股票給予 “強烈買入” 評級，十六位給予 “買入” 評級，八位給予 “持有” 評級，一位給予 “賣出” 評級。根據 MarketBeat.com 的數據，該公司目前的平均評級為 “適度買入”，平均目標價格為 611.08 美元。</p>
</div><p><strong>Get Our Latest Research Report on ISRG</strong></p>
<div class="lb-trans"><p><strong>獲取我們最新的 ISRG 研究報告</strong></p>
</div><h2>Intuitive Surgical Company Profile</h2>
<div class="lb-trans"><h2>Intuitive Surgical 公司簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.</p>
<div class="lb-trans"><p>直覺外科成立於 1995 年，總部位於加利福尼亞州的陽光谷，是一家專注於設計、製造和服務機器人輔助手術系統的醫療科技公司。該公司以其達芬奇手術系統而聞名，該系統通過將外科醫生的手部動作轉化為患者體內小型儀器的更精細、縮放的運動，從而實現微創手術。直覺外科的業務主要集中在向醫院和手術中心提供系統、儀器及相關技術，旨在提高手術室內的精確度、可視化和控制能力。</p>
</div><p>In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.</p>
<div class="lb-trans"><p>除了核心手術平台外，直覺外科還銷售一系列可重複使用和一次性使用的儀器、配件和專有軟件，併為客户提供培訓、服務和臨牀支持。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>進一步閲讀</h2>
</div><ul>
<li>Five stocks we like better than Intuitive Surgical</li>
<li>Do not delete, read immediately</li>
<li>INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off</li>
<li>Can Any Expenses Be Deducted From Capital Gains Tax?</li>
<li>Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why</li>
<li>Forget AI, This Will Be the Next Big Tech Breakthrough</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過直覺外科</li>
<li>請勿刪除，立即閲讀</li>
<li>投資者警報：微型 “$3 AI 奇蹟股票” 即將騰飛</li>
<li>任何費用可以從資本利得税中扣除嗎？</li>
<li>巴菲特、蓋茨和貝索斯悄悄拋售股票——原因在這裏</li>
<li>忘掉 AI 吧，這將是下一個重大科技突破</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=ISRG"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Intuitive Surgical Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資$1,000 在直覺外科嗎？</h2>
</div><p>Before you consider Intuitive Surgical, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮直覺外科之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而直覺外科並不在名單上。</p>
</div><p>While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然直覺外科目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Brookstone 資本管理公司增持了直覺外科公司（Intuitive Surgical, Inc.），股票代碼為$ISRG